$1.68
+0.02 (+1.20%)
Open$1.69
Previous Close$1.66
Day High$1.69
Day Low$1.66
52W High$5.50
52W Low$1.16
Volume—
Avg Volume11.2K
Market Cap6.06M
P/E Ratio—
EPS$-1.41
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+170.2% upside
Current
$1.68
$1.68
Target
$4.54
$4.54
$3.16
$4.54 avg
$6.69
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 8.11M | 7.07M | 1.27M |
| Net Income | -9,930,353 | -7,790,548 | 357.5K |
| Profit Margin | -122.5% | -116.3% | 28.2% |
| EBITDA | -10,235,780 | -8,476,282 | 531.9K |
| Free Cash Flow | — | — | 275.9K |
| Rev Growth | +14.7% | +14.7% | -7.0% |
| Debt/Equity | — | — | 0.71 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |